Who is at risk for H influenzae type B (HIB) infection, and what is the standard outpatient treatment?

Updated: Sep 30, 2020
  • Author: Justina Gamache, MD; Chief Editor: Guy W Soo Hoo, MD, MPH  more...
  • Print

H influenzae type B has been less common since the introduction of the HIB vaccine. Children younger than two years may still be at risk for H influenzae type B infection, because their immune response is not sufficient, as it is in older children. A typical regimen for outpatient therapy may include a new macrolide agent or a second-generation or third-generation cephalosporin. Cost is a potential drawback for all agents.

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!